Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Waters Corp (WAT)

Waters Corp (WAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Waters Corporation's Q1 2026 Earnings: What to Expect

Milford, Massachusetts-based Waters Corporation (WAT) is an analytical instrument manufacturer that offers practical, sustainable products for laboratory-dependent organizations. The company has a market cap of $32.5 billion and operates through two segments, Waters and TA. WAT is expected to release its Q1 2026 earnings soon.

Ahead of the event, analysts expect the company’s EPS to be $2.31 on a diluted basis, up 2.7% from $2.25 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.

Fundamentals

See More
  • Market Capitalization, $K 32,490,652
  • Shares Outstanding, K 98,165
  • Annual Sales, $ 3,165 M
  • Annual Income, $ 642,630 K
  • EBIT $ 850 M
  • EBITDA $ 1,057 M
  • 60-Month Beta 1.20
  • Price/Sales 10.07
  • Price/Cash Flow 19.53
  • Price/Book 7.55

Options Overview Details

View History
  • Implied Volatility 39.39% (+0.82%)
  • Historical Volatility 29.98%
  • IV Percentile 84%
  • IV Rank 62.85%
  • IV High 47.66% on 04/21/25
  • IV Low 25.40% on 11/26/25
  • Expected Move (DTE 2) 6.94 (2.11%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 31
  • Volume Avg (30-Day) 103
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 4,269
  • Open Int (30-Day) 4,098
  • Expected Range 321.79 to 335.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $2.31
  • Number of Estimates 8
  • High Estimate $2.35
  • Low Estimate $2.27
  • Prior Year $2.25
  • Growth Rate Est. (year over year) +2.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
284.08 +16.00%
on 03/16/26
333.68 -1.24%
on 04/15/26
+42.96 (+14.99%)
since 03/13/26
3-Month
282.77 +16.54%
on 03/13/26
401.10 -17.84%
on 01/23/26
-65.05 (-16.49%)
since 01/15/26
52-Week
275.05 +19.81%
on 08/08/25
414.15 -20.43%
on 11/25/25
+6.10 (+1.88%)
since 04/15/25

Most Recent Stories

More News
Waters Corporation's Q1 2026 Earnings: What to Expect

Waters Corporation is expected to announce its first-quarter results soon, and analysts are projecting a single-digit rise in its EPS.

XLV : 147.76 (-0.72%)
$SPX : 7,010.02 (+0.61%)
WAT : 329.70 (-0.39%)
Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

MILFORD, Mass. , April 8, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV Self-Collection Kit and...

WAT : 329.70 (-0.39%)
3 Out-of-Favor Stocks That Concern Us

3 Out-of-Favor Stocks That Concern Us

WW : 10.77 (+1.13%)
WAT : 329.70 (-0.39%)
ZG : 43.52 (+6.15%)
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

TECH : 58.60 (-0.10%)
BRKR : 39.50 (-1.00%)
WAT : 329.70 (-0.39%)
CNMD : 39.25 (-1.21%)
AVTR : 8.38 (+2.20%)
3 Mid-Cap Stocks with Open Questions

3 Mid-Cap Stocks with Open Questions

CFG : 65.44 (+0.88%)
WAT : 329.70 (-0.39%)
AMKR : 59.60 (-2.80%)
Is Waters Corporation Stock Underperforming the Dow?

Waters Corporation stock has underperformed the Dow over the past year, but analysts remain moderately bullish about its prospects.

A : 120.58 (+0.16%)
$DOWI : 48,428.41 (-0.22%)
WAT : 329.70 (-0.39%)
Waters Prices Offering of Senior Notes

MILFORD, Mass. , March 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) (the "Company" or "Waters") today announced that it has priced an offering (the "Offering") of $3.5 billion aggregate...

WAT : 329.70 (-0.39%)
Winners And Losers Of Q4: Waters Corporation (NYSE:WAT) Vs The Rest Of The Research Tools & Consumables Stocks

Winners And Losers Of Q4: Waters Corporation (NYSE:WAT) Vs The Rest Of The Research Tools & Consumables Stocks

WAT : 329.70 (-0.39%)
3 Cash-Producing Stocks Walking a Fine Line

3 Cash-Producing Stocks Walking a Fine Line

SAIA : 398.71 (-1.42%)
WAT : 329.70 (-0.39%)
SNDR : 27.28 (-3.16%)
3 Reasons to Sell WAT and 1 Stock to Buy Instead

3 Reasons to Sell WAT and 1 Stock to Buy Instead

WAT : 329.70 (-0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's...

See More

Key Turning Points

3rd Resistance Point 345.14
2nd Resistance Point 339.31
1st Resistance Point 335.14
Last Price 329.70
1st Support Level 325.14
2nd Support Level 319.31
3rd Support Level 315.14

See More

52-Week High 414.15
Fibonacci 61.8% 361.01
Fibonacci 50% 344.60
Last Price 329.70
Fibonacci 38.2% 328.19
52-Week Low 275.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.